Anisomycin activates JNK and sensitises DU 145 prostate carcinoma cells to Fas mediated apoptosis

British Journal of Cancer

Volumn 87, Issue 10, 2002, Pages 1188-1194

  Curtin, J F ^a   Cotter, T G ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Apoptosis; CD95; Fas; JNK; Prostate

Indexed keywords

ANISOMYCIN; CASPASE 8; CASPASE 9; FAS ANTIGEN; STRESS ACTIVATED PROTEIN KINASE;

APOPTOSIS; ARTICLE; CANCER SURVIVAL; CARCINOMA CELL; CELL LINE; DRUG SENSITIVITY; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; MITOCHONDRION; PRIORITY JOURNAL; PROSTATE CARCINOMA; SIGNAL TRANSDUCTION;

ANISOMYCIN; ANTIGENS, CD95; APOPTOSIS; CASPASE 8; CASPASE 9; CASPASES; ENZYME ACTIVATION; FAS LIGAND PROTEIN; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE POTENTIALS; MITOCHONDRIA; MITOGEN-ACTIVATED PROTEIN KINASES; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0037021256     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600612     Document Type: Article

References (27)

1. Chang HY, Nishitoh H, Yang X, Ichijo H, Baltimore D (1998) Activation of apoptosis signal-regulating kinase 1 (ASK1) by the adapter protein Daxx. Science 281: 1860-1863
2. Charette SJ, Lambert H, Landry J (2001) A kinase-independent function of Ask1 in caspase-independent cell death. J Biol Chem 276: 36071-36074
3. Chatterjee D, Schmitz I, Krueger A, Yeung K, Kirchhoff S, Krammer PH, Peter ME, Wyche JH, Pantazis P (2001) Induction of apoptosis in 9-nitro-camptothecin-treated DU145 human prostate carcinoma cells correlates with de novo synthesis of CD95 and CD95 ligand and down-regulation of c-FLIP(short). Cancer Res 61: 7148-7154
4. Cossarizza A, Baccarani-Contri M, Kalashnikova G, Franceschi C (1993) A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5′,6,6′-tetra-chloro-1,1′,3,3′- tetraethylbenzimidazolcarbocyanine iodide (JC-1). Biochem Biophys Res Commun 197: 40-45
5. Costa-Pereira AP, Cotter TG (1999) Camptothecin sensitizes androgen-independent prostate cancer cells to anti-Fas-induced apoptosis. Br J Cancer 80: 371-378
6. Costa-Pereira AP, McKenna SL, Cotter TG (2000) Activation of SAPK/JNK by camptothecin sensitizes androgen-independent prostate cancer cells to Fas-induced apoptosis. Br J Cancer 82: 1827-1834
7. Crawford ED, Rosenblum M, Ziada AM, Lange PH (1999) Hormone refractory prostate cancer. Urology 54: 1-7
8. Frost PJ, Belldegrun A, Bonavida B (1999) Sensitization of immunoresistant prostate carcinoma cell lines to Fas/Fas ligand-mediated killing by cytotoxic lymphocytes: Independence of de novo protein synthesis. Prostate 41: 20-30
9. Graves JD, Draves KE, Gotoh Y, Krebs EG, Clark EA (2001) Both phosphorylation and caspase-mediated cleavage contribute to regulation of the Ste20-like protein kinase Mst1 during CD95/Fas- induced apoptosis. J Biol Chem 276: 14909-14915
10. Hedlund TE, Duke RC, Schleicher MS, Miller GJ (1998) Fas-mediated apoptosis in seven human prostate cancer cell lines: Correlation with tumor stage. Prostate 36: 92-101
11. Herr I, Posovszky C, Di Marzio LD, Cifone MG, Boehler T, Debatin KM (2000) Autoamplification of apoptosis following ligation of CD95-L, TRAIL and TNF-alpha. Oncogene 19: 4255-4262
12. Holler N, Zaru R, Micheau O, Thome M, Attinger A, Valitutti S, Bodmer JL, Schneider P, Seed B, Tschopp J (2000) Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol 1: 489-495
13. Kerr JF, Wyllie AH, Currie AR (1972) Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26: 239-257
14. Kim TH, Zhao Y, Barber MJ, Kuharsky DK, Yin XM (2000) Bid-induced cytochrome c release is mediated by a pathway independent of mitochondrial permeability transition pore and Bax. J Biol Chem 275: 39474-39481
15. Micheau O, Solary E, Hammann A, Dimanche-Boitrel MT (1999) Fas ligand-independent, FADD-mediated activation of the Fas death pathway by anticancer drugs. J Biol Chem 274: 7987-7992
16. Nicholson DW (1999) Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ 6: 1028-1042
17. Parkin DM, Bray FI, Devesa SS (2001) Cancer burden in the year 2000. The global picture. Eur J Cancer 37:(Suppl 8): S4-S66
18. Peter ME, Krammer PH (1998) Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis. Curr Opin Immunol 10: 545-551
19. Petrylak DP (1999) Chemotherapy for advanced hormone refractory prostate cancer. Urology 54: 30-35
20. Rokhlin OW, Bishop GA, Hostager BS, Waldschmidt TJ, Sidorenko SP, Pavloff N, Kiefer MC, Umansky SR, Glover RA, Cohen MB (1997) Fas-mediated apoptosis in human prostatic carcinoma cell lines. Cancer Res 57: 1758-1768
21. Rokhlin OW, Glover RA, Cohen MB (1998) Fas-mediated apoptosis in human prostatic carcinoma cell lines occurs via activation of caspase-8 and caspase-7. Cancer Res 58: 5870-5875
22. Rudel T, Zenke FT, Chuang TH, Bokoch GM (1998) p21-activated kinase (PAK) is required for Fas-induced JNK activation in Jurkat cells. J Immunol 160: 7-11
23. Scaffidi C, Schmitz I, Krammer PH, Peter ME (1999a) The role of c-FLIP in modulation of CD95-induced apoptosis. J Biol Chem 274: 1541-1548
24. Scaffidi C, Schmitz I, Zha J, Korsmeyer SJ, Krammer PH, Peter ME (1999b) Differential modulation of apoptosis sensitivity in CD95 type I and type II cells. J Biol Chem 274: 22532-22538
25. Uslu R, Borsellino N, Frost P, Garban H, Ng CP, Mizutani Y, Belldegrun A, Bonavida B (1997) Chemosensitization of human prostate carcinoma cell lines to anti-fas- mediated cytotoxicity and apoptosis. Clin Cancer Res 3: 963-972
26. van Bokhoven A, Varella-Garcia M, Korch C, Miller GJ (2001) TSU-Pr1 and JCA-1 cells are derivatives of T24 bladder carcinoma cells and are not of prostatic origin. Cancer Res 61: 6340-6344
27. Wolf BB, Green DR (1999) Suicidal tendencies: apoptotic cell death by caspase family proteinases. J Biol Chem 274: 20049-20052